\begin{tabular}{rllccccc}
\toprule
{} &                                               Symbol &                                      Set &  \# Peptides & HLA-I Coverage & HLA-II Coverage & Total Coverage &  \# B-cell Epitope Regions \\
\midrule
0  &                                      $ \circledast $ &                                CD4+/CD8+ &            4 &         92.2\% &          88.5\% &         81.6\% &                          0 \\
1  &                                    $ \circledast^d $ &               CD4+/CD8+ (H2$^d$ ligands) &            4 &         93.8\% &          84.7\% &         79.5\% &                          0 \\
2  &                                    $ \circledast^b $ &               CD4+/CD8+ (H2$^b$ ligands) &            3 &         92.2\% &          84.7\% &         78.1\% &                          0 \\
3  &                                 $ \circledast^{bd} $ &    CD4+/CD8+ (H2$^b$ and H2$^d$ ligands) &            4 &         92.1\% &          84.7\% &         78.0\% &                          0 \\
4  &                                            $ \circ $ &                                     CD4+ &            3 &         91.3\% &          88.5\% &         80.8\% &                          0 \\
5  &                                          $ \circ^d $ &                    CD4+ (H2$^d$ ligands) &            3 &         91.3\% &          88.5\% &         80.8\% &                          0 \\
6  &                                          $ \circ^b $ &                    CD4+ (H2$^b$ ligands) &            3 &         76.8\% &          84.7\% &         65.0\% &                          0 \\
7  &                                       $ \circ^{bd} $ &         CD4+ (H2$^b$ and H2$^d$ ligands) &            3 &         92.2\% &          84.7\% &         78.1\% &                          0 \\
8  &                                             $ \ast $ &                                     CD8+ &            3 &         95.8\% &          61.3\% &         58.7\% &                          0 \\
9  &                                           $ \ast^d $ &                    CD8+ (H2$^d$ ligands) &            3 &         95.1\% &          76.2\% &         72.5\% &                          0 \\
10 &                                           $ \ast^b $ &                    CD8+ (H2$^b$ ligands) &            3 &         95.8\% &          61.3\% &         58.7\% &                          0 \\
11 &                                        $ \ast^{bd} $ &         CD8+ (H2$^b$ and H2$^d$ ligands) &            3 &         94.7\% &          72.6\% &         68.8\% &                          0 \\
12 &  $ \setlength{\fboxsep}{0.5pt} \boxed{\circledast} $ &                         B-Cell/CD4+/CD8+ &            3 &         88.9\% &          62.7\% &         55.7\% &                          3 \\
13 &                                       $ \boxcircle $ &                              B-Cell/CD4+ &            3 &         88.9\% &          62.7\% &         55.7\% &                          3 \\
14 &                                     $ \boxcircle^d $ &             B-Cell/CD4+ (H2$^d$ ligands) &            1 &         66.2\% &          39.9\% &         26.4\% &                          1 \\
15 &                                     $ \boxcircle^b $ &             B-Cell/CD4+ (H2$^b$ ligands) &            2 &         64.8\% &          39.4\% &         25.5\% &                          2 \\
16 &                                          $ \boxast $ &                              B-Cell/CD8+ &            3 &         90.8\% &          57.7\% &         52.4\% &                          3 \\
17 &                                        $ \boxast^d $ &             B-Cell/CD8+ (H2$^d$ ligands) &            1 &         81.8\% &          38.4\% &         31.4\% &                          1 \\
18 &                                        $ \boxast^b $ &             B-Cell/CD8+ (H2$^b$ ligands) &            2 &         89.4\% &          46.5\% &         41.5\% &                          2 \\
19 &                                     $ \boxast^{bd} $ &  B-Cell/CD8+ (H2$^b$ and H2$^d$ ligands) &            1 &         81.8\% &          38.4\% &         31.4\% &                          1 \\
20 &                                        $ \boxempty $ &                                   B-Cell &            3 &         81.8\% &          52.8\% &         43.2\% &                          3 \\
21 &                                      $ \boxempty^d $ &                  B-Cell (H2$^d$ ligands) &            3 &         81.8\% &          52.8\% &         43.2\% &                          3 \\
22 &                                      $ \boxempty^b $ &                  B-Cell (H2$^b$ ligands) &            3 &         81.8\% &          52.8\% &         43.2\% &                          3 \\
23 &                                   $ \boxempty^{bd} $ &       B-Cell (H2$^b$ and H2$^d$ ligands) &            3 &         81.8\% &          52.8\% &         43.2\% &                          3 \\
\bottomrule
\end{tabular}
